Results 291 to 300 of about 210,353 (388)
Abstract Aim Antithrombin (AT), a plasma protein with anticoagulant properties, has a long‐standing medical history, primarily for treatment of congenital AT deficiency. Accumulated clinical experiences suggest AT is a potential anticoagulant for thrombotic diseases. This study aimed to clarify the effectiveness, safety, and clinical significance of AT
Shoichi Matsutani+2 more
wiley +1 more source
The Safety of Apixaban Compared to Warfarin in Hospitalized Patients with Acute Kidney Injury. [PDF]
Al Yami MS+8 more
europepmc +1 more source
HEAL‐X: A Novel Classification System for Xylazine Associated Wounds
ABSTRACT The opioid crisis has been exacerbated by xylazine, a veterinary sedative increasingly present in illicit drugs. Xylazine causes severe skin wounds that increase the risk of morbidity. Current wound classification systems fail to address the unique features of this injury, creating a need for a tailored assessment and treatment approach.
Dante J. Terracciano+7 more
wiley +1 more source
Challenges in warfarin versus DOACs for elderly atrial fibrillation: A critique of Takagi and Ueda's study. [PDF]
Sanjana+4 more
europepmc +1 more source
Systematic Scoping on Point-of-care Monitoring of Direct Oral Anticoagulants in Patients with Non-valvular Atrial Fibrillation: Current Status and Future Perspectives in Malaysia. [PDF]
Ning Tan SS+5 more
europepmc +1 more source
Warfarin susceptibility in the roof rat, Rattus rattus, in some locations of Tokyo
Kiyohisa Naganuma+3 more
openalex +2 more sources